November 20, 2023, Tandem Diabetes Care Inc (NASDAQ: TNDM) trading session started at the price of $17.77, that was 3.54% jump from the session before. During the day, the shares moved up to $18.45 and dropped to $17.33 before settling in for the closing price of $17.79. A 52-week range for TNDM has been $13.82 – $47.17.
Top 5 EV Tech Stocks to Buy for 2023
The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".
Click Here to Download the FREE Report.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 52.10%. When this article was written, the company’s average yearly earnings per share was at -118.41%. With a float of $64.76 million, this company’s outstanding shares have now reached $65.21 million.
Let’s determine the extent of company efficiency that accounts for 2600 employees. In terms of profitability, gross margin is +50.01, operating margin of -7.71, and the pretax margin is -11.59.
Tandem Diabetes Care Inc (TNDM) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Tandem Diabetes Care Inc stocks. The insider ownership of Tandem Diabetes Care Inc is 0.68%, while institutional ownership is 108.47%. The most recent insider transaction that took place on Nov 08, was worth 95,395. In this transaction EVP & CHIEF FINANCIAL OFFICER of this company bought 6,200 shares at a rate of $15.39, taking the stock ownership to the 11,860 shares. Before that another transaction happened on Nov 08, when Company’s Chief Legal Officer bought 1,935 for $15.44, making the entire transaction worth $29,884. This insider now owns 1,935 shares in total.
Tandem Diabetes Care Inc (TNDM) Recent Fiscal highlights
Going through the last 3-months fiscal report unveiled on the 9/29/2023, it has been observed that the corporation posted -$0.38 earnings per share (EPS) during the time that was less than consensus figure (set at -$0.34) by -$0.04. This company achieved a net margin of -11.81 while generating a return on equity of -21.67. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.46 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -118.41% per share during the next fiscal year.
Tandem Diabetes Care Inc (NASDAQ: TNDM) Trading Performance Indicators
You can see what Tandem Diabetes Care Inc (TNDM) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 3.28. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.56.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.22, a number that is poised to hit -0.27 in the next quarter and is forecasted to reach -1.34 in one year’s time.
Technical Analysis of Tandem Diabetes Care Inc (TNDM)
Looking closely at Tandem Diabetes Care Inc (NASDAQ: TNDM), its last 5-days average volume was 1.78 million, which is a jump from its year-to-date volume of 1.39 million. As of the previous 9 days, the stock’s Stochastic %D was 86.29%. Additionally, its Average True Range was 1.43.
During the past 100 days, Tandem Diabetes Care Inc’s (TNDM) raw stochastic average was set at 20.00%, which indicates a significant decrease from 90.55% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 113.47% in the past 14 days, which was higher than the 75.64% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $18.93, while its 200-day Moving Average is $29.78. However, in the short run, Tandem Diabetes Care Inc’s stock first resistance to watch stands at $18.80. Second resistance stands at $19.19. The third major resistance level sits at $19.92. If the price goes on to break the first support level at $17.68, it is likely to go to the next support level at $16.95. Now, if the price goes above the second support level, the third support stands at $16.56.
Tandem Diabetes Care Inc (NASDAQ: TNDM) Key Stats
There are 65,210K outstanding shares of the company, which has a market capitalization of 1.20 billion. As of now, sales total 801,220 K while income totals -94,590 K. Its latest quarter income was 185,620 K while its last quarter net income were -32,960 K.